Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 8/20 | 0.51 |
| ▸ | MAOB | P27338 | 8/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | METAP1 | P53582 | 2/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.46 |
| ▸ | PRNP | P04156 | 1/20 | 0.46 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | MPO | P05164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29756894 | 0.92 | MAOA (0.58) | MAOAMAOBKDM4EHTTMETAP1 | |
| SCHEMBL1495967 | 0.92 | MAOA (0.58) | MAOAMAOBKDM4EHTTMETAP1 | |
| SCHEMBL115638 | 0.88 | MAOA (0.58) | MAOAMAOBKDM4EHTTMETAP1 | |
| SCHEMBL5146484 | 0.85 | MAOB (0.58) | MAOAMAOBKDM4EHTTMETAP1 | |
| SCHEMBL7510392 | 0.83 | METAP1 (0.54) | MAOAMAOBKDM4EHTTMETAP1 | |
| Sulfuric Acid SCHEMBL28143763 | 0.83 | MAOA (0.54) | MAOAMAOBKDM4EHTTMAPK14 | |
| SCHEMBL120284 | 0.81 | MAOB (0.58) | MAOAMAOBKDM4EHTTMETAP1 | |
| SCHEMBL29726357 | 0.81 | MAOB (0.58) | MAOAMAOBKDM4EHTTMETAP1 | |
| SCHEMBL268592 | 0.81 | KDM4E (0.56) | MAOBKDM4EHTTMETAP1PRNP | |
| SCHEMBL2600440 | 0.81 | KDM4E (0.59) | KDM4EHTTMETAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024025953-A2 | THERAPEUTIC USES OF UROLITHIN DERIVATIVES | VANDRIA SA (CH) | 2024-02-01 | — | — | WO | disclosed |